Spectrum Health
Grand Rapids, Michigan, 49503, United States
NCT Number: NCT00512720
To determine the effect of three different percutaneous revascularization strategies (Balloon Cryoplasty vs. Stent Placement vs. Atherectomy) in the treatment of lifestyle limiting lower extremity claudication
Looking for future studies?
Notify Me18 year–90 year
All sexes
Observational
Grand Rapids, Michigan, 49503, United States
Endovascular revascularization of the superficial femoral artery (SFA) has become one of the most commonly performed endovascular procedures.The ability to offer the patient an alternative to surgical revascularization, limited by significant morbidity and mortality, with a same-day outpatient percutaneous procedure underlies the popularity of the endovascular approach. Although surgical bypass of the SFA remains the gold standard for revascularization, it is associated with significant morbidity and mortality.Comparative data between cryoplasty, angioplasty or stenting of the SFA will ultimately be required to provide more robust evidence of the efficacy of each mode of therapy.This registry is designed to determine the efficacy of three different percutaneous revascularization strategies (Cryoplasty vs. Stent Placement vs. Atherectomy) in the treatment of lifestyle limiting lower extremity claudication.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Corewell Health West
Other
Acronym: FIX-IT Retro
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02807779
Arterial Occlusive Diseases, Arteriosclerosis
San Francisco, California, United States
View Trial DetailsNCT01938391
Arterial Occlusive Diseases, Arteriosclerosis
New York, United States
View Trial DetailsNCT02228564
Arterial Occlusive Disease, Arterial Occlusive Diseases
Little Rock, Arkansas, United States
View Trial DetailsNCT01444378
Arterial Occlusive Diseases, Arteriosclerosis
Santa Clara, California, United States
View Trial Details